Company Update

Transgene Biotek Limited has released its unaudited financial results for the quarter ending June 30, 2025. The company's total income from operations for the quarter was 25.95, with a net profit after tax of 1.94. Equity share capital stood at 649.02, and earnings per share were 0.03. These figures offer investors a look into Transgene Biotek's recent operational performance and profitability, providing a key update for stakeholders.